SFX by Ex Libris Inc.

Title:	Estimating cancer risk in HNPCC by the GRL method
Source:	European Journal of Human Genetics [1018-4813] Alarcon, Flora yr:2007

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Malhotra, D. "Association study of major risk single nucleotide polymorphisms in the common regulatory region of PARK2 and PACRG genes with leprosy in an Indian population." European journal of human genetics 14.4: 438-442.
description	2.	Vogelstein, B. "Cancer risk associated with germline DNA mismatch repair gene mutations." Human molecular genetics 6.1: 105-110.
description	3.	Dawe, Helen R R. "The Parkin co-regulated gene product, PACRG, is an evolutionarily conserved axonemal protein that functions in outer-doublet microtubule morphogenesis." Journal of cell science 5421-5430.
description	4.	Mira, Marcelo T T. "Susceptibility to leprosy is associated with PARK2 and PACRG." Nature 427.6975 (2004): 636-640.
description	5.	Fishel, R. "The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer." Cell 75.5 (1994): 1027-38.
description	6.	BRONNER, C. "MUTATION IN THE DNA MISMATCH REPAIR GENE HOMOLOG HMLH1 IS ASSOCIATED WITH HEREDITARY NONPOLYPOSIS COLON-CANCER." Nature 368.6468 (1994): 258-261.
description	7.	Hampel, H. "Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)." The New England journal of medicine 352.18 (2005): 1851-60.
description	8.	Li, J. "Association study of the single nucleotide polymorphisms of PARK2 and PACRG with leprosy susceptibility in Chinese population." European journal of human genetics 20.5 (2011): 488-9.
description	9.	"En route towards genetic medicine in practice: a clinical genetics guide in the post genomic era." European journal of human genetics 15.8 (2007): 907-907.
description	10.	Hampel, H. "Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset." Gastroenterology 129.2 (2005): 415-21.
description	11.	Vasen, H F A F. "Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)." Journal of medical genetics 44.6 (2007): 353-62.
description	12.	Ioannidis, John P A A. "'Racial' differences in genetic effects for complex diseases." Nature genetics 36.12 (2004): 1312-1318.
description	13.	Liu, M. "Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer." Cell 75.6 (1994): 1215-25.
description	14.	Adams, M D D. "Mutation of a mutL homolog in hereditary colon cancer." Science 263.5153: 1625-1629.
description	15.	Scollard, D M M. "The continuing challenges of leprosy." Clinical microbiology reviews 19.2 (2006): 338-381.
description	16.	Rose, Mark D D. "Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae." Genetics 177.2 (2007): 707-21.
description	17.	Schurr, E. "Mycobacterial infections: PARK2 and PACRG associations in leprosy." Tissue antigens 69.1 (2007): 231-3.
description	18.	Liu, B. "Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients." Nature medicine 2.2 (1996): 169-74.
description	19.	Strand, M. "Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair." Nature 365.6443 (1993): 274-6.
description	20.	de Wind, N. "Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer." Cell 82.2 (1995): 321-30.